Your browser doesn't support javascript.
loading
Versatile human cardiac tissues engineered with perfusable heart extracellular microenvironment for biomedical applications.
Min, Sungjin; Kim, Suran; Sim, Woo-Sup; Choi, Yi Sun; Joo, Hyebin; Park, Jae-Hyun; Lee, Su-Jin; Kim, Hyeok; Lee, Mi Jeong; Jeong, Inhea; Cui, Baofang; Jo, Sung-Hyun; Kim, Jin-Ju; Hong, Seok Beom; Choi, Yeon-Jik; Ban, Kiwon; Kim, Yun-Gon; Park, Jang-Ung; Lee, Hyang-Ae; Park, Hun-Jun; Cho, Seung-Woo.
Affiliation
  • Min S; Department of Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
  • Kim S; Department of Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
  • Sim WS; Cellartgen, Seoul, 03722, Republic of Korea.
  • Choi YS; Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • Joo H; Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • Park JH; Department of Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
  • Lee SJ; Department of Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
  • Kim H; Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • Lee MJ; Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • Jeong I; Department of Predictive Toxicology, Korea Institute of Toxicology, Daejeon, 34114, Republic of Korea.
  • Cui B; Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • Jo SH; Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • Kim JJ; Department of Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
  • Hong SB; Department of Materials Science and Engineering, Yonsei University, Seoul, 03722, Republic of Korea.
  • Choi YJ; Department of Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
  • Ban K; Department of Chemical Engineering, Soongsil University, Seoul, 06978, Republic of Korea.
  • Kim YG; Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • Park JU; Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • Lee HA; Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • Park HJ; Division of Cardiology, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 03312, Republic of Korea.
  • Cho SW; Department of Biomedical Sciences, City University of Hong Kong, Kowloon, 999077, Hong Kong.
Nat Commun ; 15(1): 2564, 2024 Mar 22.
Article de En | MEDLINE | ID: mdl-38519491
ABSTRACT
Engineered human cardiac tissues have been utilized for various biomedical applications, including drug testing, disease modeling, and regenerative medicine. However, the applications of cardiac tissues derived from human pluripotent stem cells are often limited due to their immaturity and lack of functionality. Therefore, in this study, we establish a perfusable culture system based on in vivo-like heart microenvironments to improve human cardiac tissue fabrication. The integrated culture platform of a microfluidic chip and a three-dimensional heart extracellular matrix enhances human cardiac tissue development and their structural and functional maturation. These tissues are comprised of cardiovascular lineage cells, including cardiomyocytes and cardiac fibroblasts derived from human induced pluripotent stem cells, as well as vascular endothelial cells. The resultant macroscale human cardiac tissues exhibit improved efficacy in drug testing (small molecules with various levels of arrhythmia risk), disease modeling (Long QT Syndrome and cardiac fibrosis), and regenerative therapy (myocardial infarction treatment). Therefore, our culture system can serve as a highly effective tissue-engineering platform to provide human cardiac tissues for versatile biomedical applications.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cellules endothéliales / Cellules souches pluripotentes induites Limites: Humans Langue: En Journal: Nat Commun Sujet du journal: BIOLOGIA / CIENCIA Année: 2024 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cellules endothéliales / Cellules souches pluripotentes induites Limites: Humans Langue: En Journal: Nat Commun Sujet du journal: BIOLOGIA / CIENCIA Année: 2024 Type de document: Article